Stories & News

Lupus Research Alliance Launches Learn From Lupus Campaign for Lupus Awareness Month

May 1, 2020 In the context of the COVID-19 crisis, one disease has taken center stage as the world found...

Lupus Research Alliance Encouraged by Lilly Looking at Potential Lupus Drug for COVID-19

April 23, 2020 The Lupus Research Alliance is pleased to share that Eli Lilly and Company entered into an agreement...

New LRA-Supported Study Discovers STAT1, a Highly Specific Target for Potential New Therapy

April 23, 2020 A new study supported by the Lupus Research Alliance discovered a way that harmful immune responses in...

Lupus Research News

New Data Points Away from Hydroxychloroquine as COVID-19 Treatment

Updated April 23, 2020 The most commonly prescribed treatment for lupus, hydroxychloroquine (best known as Plaquenil) is not effective for...

LRA Proudly Shares First Results from the COVID-19 Global Rheumatology Alliance Registry

April 20,2020 The Lupus Research Alliance is proud to share that the COVID-19 Global Rheumatology Alliance, of which the organization...

Are Autoimmune Diseases Increasing in the US?

April 16, 2020 A recently published study led by Dr. Gregg Dinse provides compelling evidence that proteins found in many...

Research Shows Benefit to Starting Belimumab Sooner Rather Than Later

April 16, 2020 Treating people with lupus earlier with belimumab (Benlysta) may work better than as a last option according...

LRA Salutes RemeGen on FDA Fast-Track Designation for Potential Lupus Treatment

April 16, 2020 The Lupus Research Alliance is pleased to share news that promises to speed up testing and review...

Letter from LRA to Top U.S. Health Officials

April 12, 2020 Today, the Lupus Research Alliance (LRA) Scientific Advisory Board Chair Dr. Gary Koretzky emailed top federal health...

Carta del presidente de LRA Ken Farber sobre la falta de Plaquenil

8 de abril de 2020 Estimado amigo de Lupus Research Alliance: Como sabrá, debido a la posibilidad de que Plaquenil (hidroxicloroquina)...

Lupus Therapeutics, filial de Lupus Research Alliance, desarrolla un estudio que se enfoca en los pacientes con lupus y la COVID-19

7 de abril de 2020 Nueva York, NY, 7 de abril de 2020 – Lupus Therapeutics, la filial de ensayos...

Lupus and COVID-19:What You Need to Know Webcast on Video

April 3, 2020 The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people with...